Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
Higher rates of unemployment and lower rates of insurance are additional barriers to receiving guideline-recommended health screenings. 1 TM individuals experience a coverage denial or other barrier ...
Pembrolizumab is under clinical development by Merck and currently in Phase II for Anal Cancer. According to GlobalData, Phase II drugs for Anal Cancer have a 19% phase transition success rate (PTSR) ...